XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2020   0        
Beginning balance at Dec. 31, 2020 $ 251,544 $ 0 $ 133 $ 112,615 $ 139,286 $ (490)
Beginning balance (in shares) at Dec. 31, 2020     13,296      
Beginning balance (in shares) at Dec. 31, 2020           38
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock (in shares)     62      
Compensation expense on restricted common stock 474   $ 1 473    
Taxes paid related to net shares settlement of equity awards (224)     (224)    
Net income (loss) (394)       (394)  
Ending balance (in shares) at Mar. 31, 2021   0        
Ending balance at Mar. 31, 2021 251,400 $ 0 $ 134 112,864 138,892 $ (490)
Ending balance (in shares) at Mar. 31, 2021     13,358      
Ending balance (in shares) at Mar. 31, 2021           38
Beginning balance (in shares) at Dec. 31, 2020   0        
Beginning balance at Dec. 31, 2020 251,544 $ 0 $ 133 112,615 139,286 $ (490)
Beginning balance (in shares) at Dec. 31, 2020     13,296      
Beginning balance (in shares) at Dec. 31, 2020           38
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (2,313)          
Ending balance (in shares) at Jun. 30, 2021   0        
Ending balance at Jun. 30, 2021 247,901 $ 0 $ 134 113,175 136,974 $ (2,382)
Ending balance (in shares) at Jun. 30, 2021     13,394      
Ending balance (in shares) at Jun. 30, 2021           213
Beginning balance (in shares) at Mar. 31, 2021   0        
Beginning balance at Mar. 31, 2021 251,400 $ 0 $ 134 112,864 138,892 $ (490)
Beginning balance (in shares) at Mar. 31, 2021     13,358      
Beginning balance (in shares) at Mar. 31, 2021           38
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock (in shares)     36      
Compensation expense on restricted common stock 421     421    
Taxes paid related to net shares settlement of equity awards (110)     (110)    
Purchase of treasury shares (in shares)           175
Purchase of treasury shares (1,892)         $ (1,892)
Net income (loss) (1,918)       (1,918)  
Ending balance (in shares) at Jun. 30, 2021   0        
Ending balance at Jun. 30, 2021 $ 247,901 $ 0 $ 134 113,175 136,974 $ (2,382)
Ending balance (in shares) at Jun. 30, 2021     13,394      
Ending balance (in shares) at Jun. 30, 2021           213
Beginning balance (in shares) at Dec. 31, 2021 0 0        
Beginning balance at Dec. 31, 2021 $ 235,910 $ 0 $ 134 114,017 130,103 $ (8,344)
Beginning balance (in shares) at Dec. 31, 2021     13,394      
Beginning balance (in shares) at Dec. 31, 2021           775
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options 21     21    
Issuance of restricted stock (in shares)     79      
Compensation expense on restricted common stock 402   $ 1 401    
Taxes paid related to net shares settlement of equity awards (359)     (359)    
Purchase of treasury shares (in shares)           247
Purchase of treasury shares (2,928)         $ (2,928)
Net income (loss) 337       337  
Ending balance (in shares) at Mar. 31, 2022   0        
Ending balance at Mar. 31, 2022 $ 233,383 $ 0 $ 135 114,080 130,440 $ (11,272)
Ending balance (in shares) at Mar. 31, 2022     13,473      
Ending balance (in shares) at Mar. 31, 2022           1,022
Beginning balance (in shares) at Dec. 31, 2021 0 0        
Beginning balance at Dec. 31, 2021 $ 235,910 $ 0 $ 134 114,017 130,103 $ (8,344)
Beginning balance (in shares) at Dec. 31, 2021     13,394      
Beginning balance (in shares) at Dec. 31, 2021           775
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 267          
Ending balance (in shares) at Jun. 30, 2022 0 0        
Ending balance at Jun. 30, 2022 $ 229,756 $ 0 $ 135 114,255 130,370 $ (15,004)
Ending balance (in shares) at Jun. 30, 2022     13,499      
Ending balance (in shares) at Jun. 30, 2022           1,310
Beginning balance (in shares) at Mar. 31, 2022   0        
Beginning balance at Mar. 31, 2022 233,383 $ 0 $ 135 114,080 130,440 $ (11,272)
Beginning balance (in shares) at Mar. 31, 2022     13,473      
Beginning balance (in shares) at Mar. 31, 2022           1,022
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options 147     147    
Issuance of restricted stock (in shares)     26      
Compensation expense on restricted common stock 184     184    
Taxes paid related to net shares settlement of equity awards (156)     (156)    
Purchase of treasury shares (in shares)           288
Purchase of treasury shares (3,732)         $ (3,732)
Net income (loss) $ (70)       (70)  
Ending balance (in shares) at Jun. 30, 2022 0 0        
Ending balance at Jun. 30, 2022 $ 229,756 $ 0 $ 135 $ 114,255 $ 130,370 $ (15,004)
Ending balance (in shares) at Jun. 30, 2022     13,499      
Ending balance (in shares) at Jun. 30, 2022           1,310